About this trial
This study examines how virtual support can enhance well-being and survivorship in men with testicular cancer. Participants in North Carolina will be randomized into two groups: one with access to a virtual support platform and the other with access to patient educational materials only. After six months, the emotional well-being, self-efficacy, financial toxicity, and quality of life of both groups will be compared at 3 months and 6 months after baseline assessments.
Eligibility criteria
Qualifiers
Men within 5 years of their initial diagnosis of germ cell testicular cancer.
The subject is willing and able to comply with study procedures based on the judgment of the investigator.
Adults aged 18-95 years old.
Electronic informed consent was obtained to participate in the study.
Disqualifiers
Woman gender
Non-English speaking
Unwilling or unable to complete informed consent.
On active treatment for another cancer.
Trial design
Treatments tested in this trial
- Virtual support
- Patient educational material
Treatment groups
Sponsors and collaborators
UNC Lineberger Comprehensive Cancer Center
Lead sponsor
United States Department of Defense
Collaborator